Opendata, web and dolomites

DeltaScan SIGNED

Public private partnership to revolutionize delirium care in hospitals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DeltaScan project word cloud

Explore the words cloud of the DeltaScan project. It provides you a very rough idea of what is the project "DeltaScan" about.

leaders    road    routine    ready    jobs    nl    benefits    priceless    eeg    monitor    substantially    detection    size    leaving    marketplace    citizens    grow    undetected    asymp    society    patients    measuring    launch    revolutionizing    blood    detect    absolute    nurses    benefiting    acute    benefit    checks    deltascan    equipped    soon    care    dying    international    europeans    pressure    checklists    majority    financial    academic    death    full    subjective    scan    scale    day    medical    tech    requirement    hospitals    guidelines    sign    least    vital    risk    million    straight    electroencephalography    prolira    clinical    173    quantify    sme    gold    bedside    severe    wish    elderly    aging    billion    fti    organizational    time    icu    capturing    earlier    brain    dementia    opinion    formed    acceptance    portable    untreated    hospitalized    hundreds    standard    delirium    created    slower    detected    market    recovery   

Project "DeltaScan" data sheet

The following table provides information about the project.

Coordinator
PROLIRA BV 

Organization address
address: PADUALAAN 8
city: UTRECHT
postcode: 3584CH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://deltascanproject.eu/
 Total cost 4˙484˙637 €
 EC max contribution 2˙994˙425 € (67%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PROLIRA BV NL (UTRECHT) coordinator 2˙420˙175.00
2    UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL (UTRECHT) participant 464˙500.00
3    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 72˙500.00
4    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 37˙250.00
5    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 0.00

Map

 Project objective

Prolira, a high-tech SME, has formed a consortium with European academic hospitals (in NL, B, G) and with Key Opinion Leaders who together are revolutionizing delirium care. This is necessary as delirium has severe consequences for patients (death, dementia, slower recovery), hospitals (organizational, time, costs), and society (costs ≈€173 billion). Every year, at least 3 million Europeans are affected by acute brain failure (delirium), especially hospitalized elderly and patients in ICU. And, the size of this problem will grow with our aging society. Delirium is an acute failure of the brain. Each day of delirium increases the risk of dementia or dying. Prolira has created a new vital sign monitor based on portable electroencephalography (EEG) technology: DeltaScan. Nurses can use it during bedside checks to scan brain activity for delirium. This simple step is as important as measuring blood pressure. Currently, nurses are only equipped with subjective checklists to detect delirium, leaving the majority of cases undetected, and untreated. With DeltaScan, delirium is detected more often and earlier, benefiting patients, hospitals, and society. Our medical consortium partners wish to implement DeltaScan into routine care, evaluating the effects and capturing the benefits. It is priceless to get financial support for this clinical testing, which is an absolute requirement for market acceptance. It is a straight road to becoming the Gold Standard in delirium detection and being included in clinical guidelines. EU H2020 FTI funding will allow us to quantify the concrete benefits of improved delirium care, allowing us access to the marketplace and allowing us to benefit society as soon as possible. As well, this funding will allow our international consortium to be well organized and ready for full-scale scale market launch. Prolira will grow substantially in the years directly after the project, creating meaningful jobs for hundreds of EU citizens.

 Deliverables

List of deliverables.
Project website online. The project website contains public information regarding the project, findings, blogs, and publications Demonstrators, pilots, prototypes 2020-04-16 11:23:35

Take a look to the deliverables list in detail:  detailed list of DeltaScan deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DELTASCAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DELTASCAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

HYDRACTFLEX (2019)

Full-scale demonstration of a flexible inline production concept for breweries, drawing on water hydraulics

Read More